期刊文献+

药物相关酶的表达或活性对结直肠癌化疗的预测作用 被引量:3

The predictive role of expression or activity of drug-related enzymes in chemotherapy for colorectal cancer
原文传递
导出
摘要 结直肠癌是常见的恶性肿瘤之一,随着新药物的应用,使其化疗效果取得了较大的进步,但是耐药仍然是结直肠癌患者化疗过程中面临的主要问题。研究显示,不同患者的肿瘤组织中药物代谢相关酶的表达及活性也不尽相同,这可能是影响化疗疗效和预后的关键因素之一。本文就此作一综述,探讨药物相关酶对结直肠癌化疗疗效和预后的预测作用。 Colorectal cancer is one of the most malignant tumors.Recently,with the approval of multiple new agents,significant progress has been made in chemotherapy for colorectal cancer.However,resistance to chemotherapy remains a major obstacle in effective treatment for colorectal cancer.Drug-related enzymes differ in different patients,which may be a key factor affecting the efficacy and prognosis of chemotherapy.This article reviews several drug-related enzymes,in order to explore their predictive roles in prediction of efficacy and prognosis of chemotherapy for colorectal cancer.
作者 赵静 张文
出处 《肿瘤》 CAS CSCD 北大核心 2011年第5期465-468,共4页 Tumor
关键词 结肠直肠肿瘤 抗肿瘤联合化疗方案 遗传药理学 预测 Colorectal neoplasms Antineoplastic combined chemotherapy protocols Pharmacogenetics Prediction
  • 相关文献

参考文献31

  • 1PARKIN D M,BRAY F,FERLAY J,et al.Global cancer statistics,2002[J].CA Cancer J Clin,2005,55(2):74-108.
  • 2SALONG D,DANENBERC K D,JOHNSON M,et al.Colorectal tumors responding to 5-fluorouracil have low gene expression levels of dihydropyrimidine dehydrogenase,thymidylate synthase,and thymidine phosphorylase[J].Clin Cancer Res,2000,6(4):1322-1327.
  • 3MEROPOL N J,COLD P J,DIASIO R B,er al.Thymidine phosphorylase expression is associated with response to capecitabine plus irinotecan in patients with metastatic colorectal cancer[J].V Clin Oncol,2006,24(25):4069-4077.
  • 4KOOPMAN M,VENDERBOSCH S,VAN TINTEREN H,et al.Predictive and prognostic markers for the outcome of chemotherapy in advanced colorectal cancer,a retrospective analysis of the phase Ⅲ randomised CAIRO study[J].Eur J Cancer,2009,45(11):1999-2006.
  • 5EDLER D,GLIMELIUS B,HALLSTROM M,et al.Thymidylate synthase expression in colorectal cancer:a prognostic and predictive marker of benefit from adjuvant fluorouracil-based chemotherapy[J].J Clin Oncol,2002,20(7):1721-1728.
  • 6TOKUNACA Y,SASAKI H,SAITO T.Clinical role of orotate phosphoribosyl transferase and dihydropyrimidine dehydrogenase in colorectal cancer treated with postoperative fluoropyrimidine[J].Surgery,2007,141(3):346-353.
  • 7YAMADA T,TANAKA N,YOKOI K,et al.Prediction of sensitivity to 5-fluorouracil (5-fu) by metabolic and target enzyme activities in colon cancer[J].Can To Kagaku Ryoho,2006,33(11):1603-1609.
  • 8SOONC R,SHAH N,SALTO-TELLEZ M,et al.Prognostic significance of thymidylate synthase,dihydropyrimidine dehydrogenase and thymidine phosphorylase protein expression in colorectal cancer patients treated with or without 5-fluorouracil-based chemotherapy[J].Ann Oncol,2008,19(5):91 5-919.
  • 9JENSEN S,VAINER B,KRUHOFFER M,et al.Microsatellite instability in colorectal cancer and association with thymidylate synthase and dihydropyrimidine dehydrogenase expression[J].BMC Cancer,2009,9:25.
  • 10NEAL J M,PHILIP J C,ROBERT B D,et al.Thymidine phosphorylase expression is associated with response to capecitabine plus irinotecan in patients with metastatic colorectal cancer[J].J Clin Oncol,2006,24(25):4069-4077.

同被引文献50

  • 1肖秀英,于宝华,王丽莎,倪淑娟,杨晓燕,朱玉芬.结直肠癌原发及转移灶中PI3K、p-Akt及mTOR的表达及意义[J].中国癌症杂志,2011,21(4):247-250. 被引量:7
  • 2徐皖湘,陈振东.二氢嘧啶脱氢酶活性在食管癌5-FU化疗中的应用价值[J].安徽医科大学学报,2007,42(1):84-86. 被引量:3
  • 3Park DJ, Lenz HJ. Determinants of chemosensitivity in gastric canc- er [ J ]. Curr Opin Pharmacol ,2006,6 (4) :337 - 344.
  • 4Li Q, Part D, Zhang JH, et al. Identification of the thymidylate syn- thase within the genome of white spot syndrome virus [ J]. Gcn Vir- ol, 2004,85 (7) :2035 - 2044.
  • 5Popat S, Matakidou A, Houlston RS. Thymidylate synthase expres- sion and prognosis in colorectal cancer: a systematic review and me- ta - analysis [ J ]. Clin Oncol,2004,22 ( 3 ) :529 - 536.
  • 6Marsh S, Collie DES, Li T, et al. Ethnic variarion in the thymidylate synrhase enhancer region polym orphism among Caucasian and Asi- an population [J]. Genomics,1999,58(3) :310 -312.
  • 7Mandola MV,Stcehlmacher J,Zhang W,et al. A 6bp polymorphism in the thymidylate synthase gene causes message instability and is associated with decreased intratumoral TS Mrna levels [ J ]. Phar- macogenetics,2004,14 (5) :319 - 327.
  • 8Merkelbach BS, Hans V, Marhiak M, et al. Associations between polymorphisms in the thymidylate synthase gene, the expression of thymidy|ate synthase mRNA and the microsatellite instability phe- notype of col.orectal cancer [J]. Oncol Rep,2004,11(4) :839 - 843.
  • 9Anatori F, Di Paolo A, Del Tscca M, et al. Thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase ex- pression in colorectal cancer and normal mueosa in patients [ J]. 2006,16( 11 ) :809 -816.
  • 10Chu E, Koeller DM, Johnston PG, et al. Regulation of thymidylate synthase in human colon cancer cells treated with 5 - fluorouracil and interferon - gamma [ J ]. Mol Pharmacol, 1992,43 ( 4 ) : 527 - 533.

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部